Critical Contrast: Centene Corporation (CNC) and Its Competitors
Centene Corporation (NYSE: CNC) is one of 14 public companies in the “Managed Health Care” industry, but how does it contrast to its rivals? We will compare Centene Corporation to related companies based on the strength of its institutional ownership, risk, valuation, profitability, analyst recommendations, dividends and earnings.
This table compares Centene Corporation and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Centene Corporation Competitors||1.72%||10.53%||3.42%|
Valuation & Earnings
This table compares Centene Corporation and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Centene Corporation||$43.65 billion||$2.19 billion||20.56|
|Centene Corporation Competitors||$52.30 billion||$3.74 billion||17.71|
Centene Corporation’s rivals have higher revenue and earnings than Centene Corporation. Centene Corporation is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
92.1% of Centene Corporation shares are held by institutional investors. Comparatively, 90.2% of shares of all “Managed Health Care” companies are held by institutional investors. 3.0% of Centene Corporation shares are held by company insiders. Comparatively, 2.4% of shares of all “Managed Health Care” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Volatility and Risk
Centene Corporation has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Centene Corporation’s rivals have a beta of 0.76, indicating that their average share price is 24% less volatile than the S&P 500.
This is a breakdown of recent recommendations for Centene Corporation and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Centene Corporation Competitors||79||872||1432||22||2.58|
Centene Corporation currently has a consensus target price of $94.94, suggesting a potential upside of 1.50%. As a group, “Managed Health Care” companies have a potential upside of 1.48%. Given Centene Corporation’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Centene Corporation is more favorable than its rivals.
Centene Corporation beats its rivals on 9 of the 13 factors compared.
About Centene Corporation
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.
Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with MarketBeat.com's FREE daily email newsletter.